Sarah Heynemann

10PUBLICATIONS
15CO-AUTHORS
Ethical use of new technologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 11, 2026
Uncertainty and novel clinical trial designs in oncology - when should equipoise matter?

|May 07, 2026
Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials.

|Dec 20, 2023
Therapeutic misunderstandings in modern research.

Sarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan

|Feb 23, 2023
When research becomes practice: the concept of the therapeutic misconception and challenges to consent in clinical trials.

Sarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan

|Dec 23, 2022
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.

Sarah Heynemann, Vinay Vanguru, Stephen Adelstein

|Dec 23, 2021
Developments in systemic therapies for the management of lung cancer.

Sarah Heynemann, Paul Mitchell

Pageof 2

Frequent Collaborators

2 joint publications

Jennifer Philip

2 joint publications

Julia Lai-Kwon

2 joint publications

Nicolas H Hart

2 joint publications

Raymond J Chan